These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 9488064)

  • 41. Surgical management for upper urinary tract transitional cell carcinoma.
    Rai BP; Shelley M; Coles B; Biyani CS; El-Mokadem I; Nabi G
    Cochrane Database Syst Rev; 2011 Apr; (4):CD007349. PubMed ID: 21491399
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evidence for cyclophosphamide-induced transitional cell carcinoma in a renal transplant patient.
    Tuttle TM; Williams GM; Marshall FF
    J Urol; 1988 Nov; 140(5):1009-11. PubMed ID: 3050150
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Synchronous bilateral primary transitional cell carcinoma of the upper urinary tracts: ten patients with more than five years of follow-up.
    Kang CH; Yu TJ; Hsieh HH; Yang JW; Shu K; Shiue YL
    Urology; 2004 Feb; 63(2):380-2. PubMed ID: 14972504
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Upper tract tumour after radical cystectomy for transitional cell carcinoma of the bladder: incidence and risk factors.
    Sved PD; Gomez P; Nieder AM; Manoharan M; Kim SS; Soloway MS
    BJU Int; 2004 Oct; 94(6):785-9. PubMed ID: 15476508
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The development of bladder tumors and contralateral upper urinary tract tumors after primary transitional cell carcinoma of the upper urinary tract.
    Kang CH; Yu TJ; Hsieh HH; Yang JW; Shu K; Huang CC; Chiang PH; Shiue YL
    Cancer; 2003 Oct; 98(8):1620-6. PubMed ID: 14534877
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Transitional cell tumors of the renal pelvis and ureter associated with capillarosclerosis indicating analgesic abuse.
    Palvio DH; Andersen JC; Falk E
    Cancer; 1987 Mar; 59(5):972-6. PubMed ID: 3815276
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Non-metastatic upper tract transitional cell carcinoma: single center experience.
    Demirci U; Canda AE; Dede DS; Cakici OU; Akinci MB; Yalcin B
    Asian Pac J Cancer Prev; 2013; 14(2):1131-2. PubMed ID: 23621200
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Urothelial lesions in Chinese-herb nephropathy.
    Cosyns JP; Jadoul M; Squifflet JP; Wese FX; van Ypersele de Strihou C
    Am J Kidney Dis; 1999 Jun; 33(6):1011-7. PubMed ID: 10352187
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Outcomes of hand-assisted laparoscopic nephroureterectomy for managing upper urinary tract transitional cell carcinoma--China Medical University Hospital experience.
    Chen CH; Wu HC; Chen WC; Yeh CC; Chen CC; Chang CH
    Urology; 2005 Apr; 65(4):687-91. PubMed ID: 15833509
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Surveillance of upper urinary tract transitional cell carcinoma: the role of ureteroscopy, retrograde pyelography, cytology and urinalysis.
    Chen GL; El-Gabry EA; Bagley DH
    J Urol; 2000 Dec; 164(6):1901-4. PubMed ID: 11061876
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Carcinoma of the urinary tract and analgesic abuse.
    Taylor JS
    Med J Aust; 1972 Feb; 1(9):407-9. PubMed ID: 5024397
    [No Abstract]   [Full Text] [Related]  

  • 52. Upper urinary tract recurrence following radical cystectomy for bladder cancer: a meta-analysis on 13,185 patients.
    Picozzi S; Ricci C; Gaeta M; Ratti D; Macchi A; Casellato S; Bozzini G; Carmignani L
    J Urol; 2012 Dec; 188(6):2046-54. PubMed ID: 23083867
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nomograms including nuclear matrix protein 22 for prediction of disease recurrence and progression in patients with Ta, T1 or CIS transitional cell carcinoma of the bladder.
    Shariat SF; Zippe C; Lüdecke G; Boman H; Sanchez-Carbayo M; Casella R; Mian C; Friedrich MG; Eissa S; Akaza H; Sawczuk I; Serretta V; Huland H; Hedelin H; Rupesh R; Miyanaga N; Sagalowsky AI; Wians F; Roehrborn CG; Lotan Y; Perrotte P; Benayoun S; Marberger MJ; Karakiewicz PI
    J Urol; 2005 May; 173(5):1518-25. PubMed ID: 15821471
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Renal pelvic carcinoma in the Hunter Valley.
    Orell SR; Nanra RS; Ferguson NW
    Med J Aust; 1979 Nov; 2(10):524, 555-7. PubMed ID: 530147
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Risk factors for intravesical recurrence after surgical management of transitional cell carcinoma of the upper urinary tract.
    Terakawa T; Miyake H; Muramaki M; Takenaka A; Hara I; Fujisawa M
    Urology; 2008 Jan; 71(1):123-7. PubMed ID: 18242379
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Contralateral nephroureterectomy for renal transplant recipients with unilateral upper urinary tract transitional cell carcinoma: a report of 12 cases.
    Hou HJ; Xiao J; Tian Y
    Transplant Proc; 2013; 45(6):2203-6. PubMed ID: 23850405
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Significance of epidermal growth factor receptor and c-erbB-2 protein expression in transitional cell cancer of the upper urinary tract for tumour recurrence at the urinary bladder.
    Imai T; Kimura M; Takeda M; Tomita Y
    Br J Cancer; 1995 Jan; 71(1):69-72. PubMed ID: 7819052
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Management of patients with upper urinary tract transitional cell carcinoma.
    Raman JD; Scherr DS
    Nat Clin Pract Urol; 2007 Aug; 4(8):432-43. PubMed ID: 17673914
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Upper urinary tract transitional cell carcinoma after total cystectomy for bladder cancer.
    Lindell O; Lehtonen T
    Ann Chir Gynaecol; 1985; 74(6):288-93. PubMed ID: 4096482
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of ureteropelvic transitional cell carcinoma with bladder transitional cell carcinoma using an image analyzer.
    Shiina H; Igawa M; Urakami S; Shirakawa H; Ishibe T
    Urol Int; 1996; 56(3):163-8. PubMed ID: 8860737
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.